San Francisco, California-based Hinge Health Inc., a Digital MSK (musculoskeletal) Clinic™, has named industry veteran Jim Pursley as its new President.
Jim Pursley Named Hinge Health’s President
1 min read Premium comments
Secondary#hingehealth#jimpursley
Hinge Health provides MSK solutions for employers and health plans. Its clinical care model provides members with access to “doctors of physical therapy, physicians, health coaches, and technology such as wearable sensors to guide exercise therapy.”
Pursley has been an advisor to Hinge Health since 2017. In his most recent role as Livongo Health’s Chief Commercial Officer, Pursley helped to grow Livongo into the world’s “leading consumer focused chronic condition management company.” A former collegiate athlete, Pursley has held executive leadership roles at Intel-GE Care Innovations and GE Healthcare.
Pursley earned his bachelor’s degree in Management Science & Information Systems from Pennsylvania State University and his MBA from Northwestern University’s Kellogg School of Management. He is a Heart of Chicago Board member for the American Heart Association and formerly served as the President of the Board of Directors of Clapham School.
Hinge Health CEO and Cofounder Dan Perez told OTW, “We’re thrilled to welcome Jim, a true trailblazer in digital health care. As the founding Chief Commercial Officer of Livongo Health, he helped lead the company to the $18.5 billion acquisition by Teladoc. We have been fortunate to have him as an adviser over the last four years and are excited for him to lead Hinge Health’s continued commercial growth.”
Pursley expressed his excitement about joining the Hinge Health team, “As a former collegiate athlete, I was quickly drawn to Hinge Health’s mission to transform the way that chronic pain and musculoskeletal health is conceived and delivered.”
He continued, “It’s a privilege to join the incredible Hinge Health team and I’m excited to be part of transforming the way in which we approach musculoskeletal care from prevention to intervention and recovery.”
For OTW’s coverage of Hinge Health’s recent fundraise, see “Ortho Digital Health Company Raises $300 Million.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.